Huaren Pharmaceutical Co., Ltd. (300110.SZ) SHZ

2.81

-0.06(-2.09%)

Updated at June 02 03:04PM

Currency In CNY

Valuation

Market Cap3.72B
Enterprise Value4.19B
P/E Ratio-7.17
PEG Ratio-0.11
Price/Sales Ratio2.5
Price/Book Ratio3.89
Enterprise/Revenue3.04
Enterprise/EBITDA-11.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.35
Operating Margin-0.34

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.42

Income Statement

Revenue1.32B
Revenue/Share1.12
Gross Profit489.54M
EBITDA-308.5M
Net Income-462.9M
Diluted EPS-0.39

Balance Sheet

Total Cash185.49M
Total Cash/Share0.16
Total Debt902.43M
Total Debt/Equity1.06
Current Ratio0.82
Book Value Per Share0.78

Price History

52-Week Change-13.8
52-Week High3.75
52-Week Low2.73
Moving Average 50 Days3.09
Moving Average 200 Days3.27

Statistics

Average Volume29.32M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split Factor287:250
Last Split DateFebruary 09, 2018